On the contrary, in this study of 25 420 US Medicare recipients 65 years and older, a significant trend towards reduced MI rates were noted with increasing quartiles of risk. 33 For men in the highest prognostic MI risk quartile, treatment with TTh was associated with reduced risk (HR = 0.69; 95% CI = 0.53–0.92).
1
—
—